<DOC>
	<DOCNO>NCT00888914</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy RT001 treat moderate severe lateral canthal line adult .</brief_summary>
	<brief_title>Safety Efficacy Study RT001 Treat Moderate Severe Lateral Canthal Lines</brief_title>
	<detailed_description>This multi-center study evaluate safety efficacy four different dos RT001 compare vehicle apply single , bilateral topical application least 60 subject moderate severe lateral canthal line . Subjects randomize one five treatment group 1:1:1:1:1 ratio . Follow-up visit schedule 28 day post-treatment . The safety efficacy Cohort 1 ( Day 14 visit ) assess prior decision enroll subject Cohort 2 additional dos treatment regimen need evaluate .</detailed_description>
	<criteria>Female male ; 30 55 year age Bilateral lateral canthal line rat moderate advance Willing refrain receive facial filler , laser treatment , use product affect remodel product may cause active dermal response treatment area begin Screening End Study Women childbearing potential must practice willing continue use effective method birth control course study Muscle weakness paralysis area receive study treatment Active skin disease irritation treatment area Undergone procedure may affect lateral canthal region past 12 month prior Screening Previous treatment botulinum toxin ( serotype ) head neck area within 9 month prior Baseline ( Day 0 ) Use topical steroid either treatment area use medication suppress immune system 30 day prior Screening continue End Study ( Day 28 ) Any abnormality electrocardiogram ( ECG ) Screening history clinically significant arrhythmia , unstable angina , myocardial infarction congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Lateral Canthal Lines</keyword>
	<keyword>Crow 's Feet</keyword>
	<keyword>Facial Wrinkles</keyword>
</DOC>